US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1  2  3  4    6    8  9  10  
RANKL Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... function. Binding of RANKL to RANK leads to the activation of signaling modules such as NF-kappa B, mitogen activated protein kinases (MAPK's), protein kinase C (PKC), Ca2+/Calcineurin/nuclear factor of activated T cells (NFAT) and phosphatidyl ...  |  read more...
USD 6,746
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... RNA (miRNA, RNAi & siRNA) drugs in 152 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last years amount to another 28 drugs. ...  |  read more...
USD 4,496
Targeting Cell Adhesion Molecules (CAMs) for the Treatment of Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... There are four main groups: the integrin family, the immunoglobulin superfamily, selectins, and cadherins. There are today 104 companies plus partners developing 106 targeting CAMs drugs in 330 developmental projects in cancer. In addition, there ...  |  read more...
USD 4,496
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... and the accumulated number of ceased drugs over the last years amount to another 249 drugs. Androgen Receptor Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on ...  |  read more...
USD 6,746
Angiogenesis in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... amount to another 207 drugs. Angiogenesis In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 277 different targets. All included ...  |  read more...
USD 6,746
Antibodies in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... of therapeutic antibodies. There are today 354 companies plus partners developing 707 antibody drugs in 1875 developmental projects in cancer. In addition, there are 6 suspended drugs and the accumulated number of ceased drugs over ...  |  read more...
USD 6,746
Biologicals in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... in cancer. In addition, there are 26 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 1009 drugs. Biologicals In Oncology Drug Pipeline Update lists all drugs and ...  |  read more...
USD 11,246
Breast Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... below five years. There are today 400 companies plus partners developing 540 drugs targeting breast cancer in development. In addition, there are 8 suspended drugs and the accumulated number of ceased drugs over the last ...  |  read more...
USD 6,746
Calcium Signaling Pathway in Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... the last years amount to another 120 drugs. Calcium Signaling Pathway In Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to ...  |  read more...
USD 6,746
Cancer Drugs in the FDA Fast Lane Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... review (1992) to the most recent Breakthrough therapy (2012). This pipeline update, Cancer Drugs in the FDA Fast Lane, gives a thorough account on which cancer drugs the FDA has chosen to favor for one ...  |  read more...
USD 4,496
Cancer Stem Cells Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today 329 companies plus partners developing 448 cancer stem ...  |  read more...
USD 6,746
CAR-T Therapies in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... drug. In this regard, we have already witnessed the stellar results by Novartis and Penn University on CTL019 that left 92% of patients cancer-free in a leukemia study and performed well against lymphomas in clinical ...  |  read more...
USD 3,128
Cellular Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... years amount to another 65 drugs. Cellular Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 59 different targets. ...  |  read more...
USD 4,496
Chemokine Signaling Pathway in Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... host response. In addition, chemokines regulate plethora of biological processes of hematopoietic cells to lead cellular activation, differentiation and survival. There are today 173 companies plus partners developing 224 chemokine signaling pathway targeting drugs in ...  |  read more...
USD 6,746
Cytokine Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... amount to another 11 drugs. Cytokine Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 20 different targets. All ...  |  read more...
USD 4,496
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... and the accumulated number of ceased drugs over the last years amount to another 360 drugs. Egfr1 Signaling Pathway In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each ...  |  read more...
USD 6,746
Epigenetic Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... in oncology (eg, Azacitidine, Decitabine, Vorinostat, Romidepsin, Ruxolitinib). Today a majority of drugs targets histone methylation and acetylation, also frequently dysregulated in cancer cells, in the form of inhibitors of histone acetyltransferases (HATs), histone deacetylases ...  |  read more...
USD 4,496
Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... focal adhesions, where bundles of actin filaments are anchored to transmembrane receptors of the integrin family through a multi-molecular complex of junctional plaque proteins. There are today 351 companies plus partners developing 502 focal adhesion ...  |  read more...
USD 6,746
ErbB Signaling Pathway in Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... closely related members of this RTK family -epidermal growth factor receptor (EGFR, also known as ErbB-1 or HER1), ErbB-2 (HER2), ErbB-3 (HER3), and ErbB-4 (HER4)-induces the formation of receptor homo- and heterodimers and the activation ...  |  read more...
USD 6,746
Anti Dermatomycosis Skin Drugs Markets in China
1/1/2015 | published by: Asia Market Information & Development Company
... to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new ...  |  read more...
USD 4,000
Fierce 15 in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... not at being 'me-too'. This unique product, the 'Fierce 15 in Oncology Drug Pipeline Update' gathers the last five years (2010-2014) of Fierce 15 awards and identifies that no less than 45 of these biotech ...  |  read more...
USD 4,478
Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... last years amount to another 91 drugs. Targeting Metabolic Pathways In Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 145 ...  |  read more...
USD 6,746
Gene Therapy in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... years amount to another 103 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 107 different targets. ...  |  read more...
USD 6,746
Sjogren's Syndrome - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Sjogren's Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cryptosporidiosis - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Cryptosporidiosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
1  2  3  4    6    8  9  10